19 July 2022

The SPIDI collection aims to assess the prognostic value of MRI-DWI (new form of MRI research) and biomarkers (brain-specific proteins in cerebrospinal fluid) in the first 24 hours after the occurrence of a spinal cord injury as a result of trauma. The collections consists of cerebral spinal fluid (CSF) and associated clinical data.

  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


TETRO-trial

30 March 2023

The TETRO-trial is a study on a new treatment for compulsive/obsessive-compulsive disorder.

read more

Archipelago

30 March 2023

Archipelago of Ovarian Cancer Research (AOCR) is a national platform for centralizing and expanding scientific research into ovarian cancer.

read more

EVA-trial

30 March 2023

The Department of Obstetrics and Gynecology established the EVA trial biobank with the aim of enabling scientific research into high blood pressure in pregnancy.

read more

Theme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard

30 March 2023

In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.

read more

Health-RI receives definitive follow-up funding from the National Growth Fund

30 March 2023

The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.

read more

Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl)

19 July 2022

The Ministry of Health, Welfare and Sport (VWS) is currently preparing a Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl) which will serve in the future as a specific legal framework for the (further) use of body tissue for medical scientific research.

read more